Skip to main content

Table 3 Outcomes (intention-to-treat)

From: Economic evaluation of an experience sampling method intervention in depression compared with treatment as usual using data from a randomized controlled trial

  ESM-I (n = 33) Pseudo-intervention (n = 35) Control (n = 33) Regression coefficients; B (95% confidence interval)a
ESM-I vs Control ESM-I vs Pseudo-intervention
HDRS (at 32 weeks)
 HDRS scorea 10.8 (7.1) 13 (7.12) 15.3 (8.3) −3.1 (−6.2; 0.01) −1.13 (−4.18; 1.92)
 Improvement since baseline 2.7 (6.1) 2.1 (5.9) 0.24 (7.5) 3.1 (−0.01; 6.2) 1.13 (−1.92; 4.18)
 Symptomatic remissionb 11 (33.3) 9 (25.7) 6 (18.2) OR = 2.65 (0.79; 8.9) OR = 1.84 (0.59; 5.7)
QALYs (over 32 weeks)
 EQ-5D, UK tariff 0.45 (0.17) 0.38 (0.18) 0.32 (0.18) 0.08 (0.02; 0.10)* 0.04 (−0.02; 0.10)
  1. HDRS 17-item Hamilton Depression Rating Scale, QALY quality adjusted life year, EQ-5D EuroQol-5D-3L
  2. *p < 0.05
  3. aControlled for baseline values
  4. bSymptomatic remission = HDRS score ≤ 7